Table 5.

Comparison of antibiotic susceptibility between ESBL and non-ESBL producing isolates

Antibiotic	ESBL						Non ESBL						P value
	S		I		R		S		I		R
	%	N	%	N	%	N	%	N	%	N	%	N
Amikacin	82.5	137	0.6	1	16.9	28	80.7	126	5.8	9	13.5	21	0.02
Cephalexin	13.8	23	0	0	86.1	143	53.2	83	0	0	46.7	73	0
Cefotaxime	18.6	31	1.8	3	79.5	132	69.8	109	4.4	7	25.6	40	0
Ceftriaxone	19.2	32	1.8	3	78.9	131	71.1	111	6.4	10	22.4	35	0
Ceftazidime	19.2	32	1.2	2	79.5	132	73.07	114	11.5	18	15.3	24	0
Cefuroxime	16.2	27	3.01	5	80.7	134	64.7	101	8.3	13	26.9	42	0
Co-trimoxazole	19.2	32	1.2	2	79.5	132	37.1	58	5.1	8	57.6	90	0
Meropenem	83.1	138	6.02	10	10.8	18	83.3	130	7.05	11	9.6	15	0.88
Ciprofloxacin	52.4	87	9.03	15	38.5	64	76.2	119	7.6	12	16.02	25	0
Doxycycline	24.6	41	6.6	11	68.6	114	42.9	67	9.6	15	47.4	74	0.001
Gentamicin	56.02	93	5.4	9	38.5	64	66.02	103	5.1	8	28.8	45	0.16
Imipenem	72.8	121	12.6	21	14.4	24	78.8	123	12.8	20	8.3	13	0.03
Amoxicillin/clauvanic acid	28.3	47	18.07	30	53.6	89	44.8	70	10.8	17	44.2	69	0.006
Amoxicillin	3.01	5	0	0	96.9	161	10.2	16	1.9	3	87.8	137	0.006